IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 203 filers reported holding IMPAX LABORATORIES INC in Q2 2016. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $10,000 | +25.0% | 506 | 0.0% | 0.01% | 0.0% |
| Q4 2017 | $8,000 | -20.0% | 506 | 0.0% | 0.01% | -28.6% |
| Q3 2017 | $10,000 | +25.0% | 506 | 0.0% | 0.01% | +16.7% |
| Q2 2017 | $8,000 | +33.3% | 506 | 0.0% | 0.01% | +50.0% |
| Q1 2017 | $6,000 | -14.3% | 506 | 0.0% | 0.00% | -33.3% |
| Q4 2016 | $7,000 | -36.4% | 506 | 0.0% | 0.01% | -50.0% |
| Q3 2016 | $11,000 | -21.4% | 506 | 0.0% | 0.01% | -25.0% |
| Q2 2016 | $14,000 | -12.5% | 506 | 0.0% | 0.02% | +6.7% |
| Q1 2016 | $16,000 | -23.8% | 506 | 0.0% | 0.02% | -11.8% |
| Q4 2015 | $21,000 | +23.5% | 506 | 0.0% | 0.02% | -19.0% |
| Q3 2015 | $17,000 | -26.1% | 506 | 0.0% | 0.02% | -16.0% |
| Q2 2015 | $23,000 | -4.2% | 506 | 0.0% | 0.02% | +4.2% |
| Q1 2015 | $24,000 | +50.0% | 506 | 0.0% | 0.02% | +41.2% |
| Q4 2014 | $16,000 | – | 506 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aravt Global | 2,670,000 | $125,143,000 | 9.40% |
| Krensavage Asset Management, LLC | 410,944 | $19,261,000 | 8.77% |
| BANBURY PARTNERS LLC | 292,660 | $13,717,000 | 8.70% |
| Slate Path Capital LP | 1,935,000 | $90,693,000 | 5.72% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 285,000 | $13,358,000 | 4.69% |
| Orbimed Advisors | 6,678,000 | $312,998,000 | 2.67% |
| Pennant Capital Management, LLC | 2,025,000 | $94,912,000 | 1.78% |
| Iguana Healthcare Management, LLC | 75,000 | $3,515,000 | 1.48% |
| Leonard Capital Management, Inc. | 89,235 | $4,182,000 | 1.44% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 250,000 | $11,718,000 | 1.23% |